Advanced Concepts in Human Immunology: Prospects for Disease Control

Jain, Pooja, Ndhlovu, Lishomwa C.

  • 出版商: Springer
  • 出版日期: 2020-08-13
  • 售價: $10,750
  • 貴賓價: 9.5$10,213
  • 語言: 英文
  • 頁數: 403
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3030339459
  • ISBN-13: 9783030339456
  • 相關分類: 人工智慧
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book provides a thorough distillation of current research, focused on the theoretical and scientific aspects of the human immune system. Coverage includes host-virus interactions in infectious disease, host immune response in cancer, allergic diseases, neuroinflammatory diseases, and autoimmune disorders. Attention is given to understanding human immune behavior, with particular emphasis on the role of immunoproteomics in immunotherapy, neuroprotective immunity for neurodegenerative and neuroinfectious disease, leukemia-associated dendritic cell induction of adaptive immunity dysregulation/dysfunction, and the role of immune checkpoint inhibitors in the cancer, infection and neuroinflammation. Human Immunology is intended for both clinicians and researchers in academia and industry.

作者簡介

Pooja Jain, PhD, is a Professor in the Department of Microbiology and Immunology as well as Neurobiology and Anatomy at the Drexel University College of Medicine located in Philadelphia, USA. Her research focuses on the host-pathogen interactions underlying Adult T-Cell Leukemia Lymphoma (ATLL) induced by Human T-cell leukemia virus type 1 (HTLV-1). In addition, her Dr. Jain's laboratory is engaged in testing novel targets for myeloid cell-immunotherapy against neuroinflammtory diseases such as Multiple Sclerosis and HAM/TSP (HTLV-associated myelopathy/tropical spastic paraparesis).

Lishomwa C. Ndhlovu, PhD, is a Professor at the John A. Burns School of Medicine, University of Hawaii. His research focuses on understanding the impact of HIV on the immune system as well as how this host-HIV interaction will inform potential clinical applications in balancing strategies to slow or eliminate HIV infection and optimize quality of life outcomes. Dr. Ndhlovu's laboratory is also investigating the role of negative checkpoint regulators (NCR) in HIV, as potential immunotherapy that reverse immune perturbation in HIV.